Verquvo 5® Vericiguat Tablets

Verquvo 5 mg contains vericiguat and is used to reduce the risk of cardiovascular death and heart failure-related hospitalisation in eligible adults with symptomatic chronic heart failure and reduced or mildly reduced ejection fraction following a recent worsening episode requiring hospitalisation or intravenous diuretics

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.